Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SMD Rise PCLBKK:SMD100 -5.81%61 Return-on-Tangible-Asset is 8.41% as of Jun. 2026, which is 36% below its 10-year median of 13.08. GuruFocus rates BKK:SMD100 with a GF Score™ of 61/100 and a GF Value™ of ฿5.28 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 120 Medical Distribution companies, SMD Rise PCL ranks better than 62.5% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. SMD Rise PCL's annualizedNet Income for the quarter that ended in Jun. 2026 was ฿115 Mil. SMD Rise PCL's average total tangible assets for the quarter that ended in Jun. 2026 was ฿1,363 Mil. Therefore, SMD Rise PCL's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 8.41%.
The historical rank and industry rank for SMD Rise PCL's Return-on-Tangible-Asset or its related term are showing as below:
BKK:SMD100'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 0.79 Med: 13.08 Max: 31.72
Current: 3.7
During the past 8 years, SMD Rise PCL's highest Return-on-Tangible-Asset was 31.72%. The lowest was 0.79%. And the median was 13.08%.
BKK:SMD100's Return-on-Tangible-Asset is ranked better than 62.5% of 120
companies
in the Medical Distribution industry
Industry Median: 2.565
vs BKK:SMD100: 3.70
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
SMD Rise PCL Return-on-Tangible-Asset Related Terms
SMD Rise PCL Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100 vs MCK, COR, CAH: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, SMD Rise PCL's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 8.41% mean?
SMD Rise PCL (BKK:SMD100) has a Return-on-Tangible-Asset of 8.41% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on SMD Rise PCL and its competitors. This is 36% below median its historical median of 13.08. Over the past decade, SMD Rise PCL's Return-on-Tangible-Asset has ranged from 0.79 to 31.72. According to the industry distribution chart, SMD Rise PCL ranks #45 out of 120 companies in the Medical Distribution industry, placing it in the top 37.5%.
Is SMD Rise PCL's Return-on-Tangible-Asset too high?
SMD Rise PCL's current Return-on-Tangible-Asset of 8.41% is 36% below median its 10-year median of 13.08. Over the past 10 years, this metric has ranged from a low of 0.79 to a high of 31.72. The Medical Distribution industry median Return-on-Tangible-Asset is 2.57. SMD Rise PCL's value of 8.41% is 227.9% above this industry median. Based on the distribution chart, SMD Rise PCL ranks #45 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, SMD Rise PCL has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's Return-on-Tangible-Asset compare to MCK and COR?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #45 out of 120 companies for Return-on-Tangible-Asset. This puts SMD Rise PCL in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.57. SMD Rise PCL's value of 8.41% is 227.9% above this benchmark. Historically, SMD Rise PCL's own Return-on-Tangible-Asset has ranged from 0.79 to 31.72 over the past decade. While the company's 10-year median is 13.08 vs. the industry median of 2.57, SMD Rise PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.57, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMD Rise PCL's current Return-on-Tangible-Asset of 8.41% is 227.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current Return-on-Tangible-Asset is 8.41%, which is 36% below median its own 10-year median of 13.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
Based on GuruFocus' analysis, SMD Rise PCL (BKK:SMD100) is currently considered Possible Value Trap. The stock's GF Value™ is ฿5.28, compared to a current price of ฿1.62 — trading 69.3% below its estimated fair value. The current Return-on-Tangible-Asset is 8.41%, which is 36% below median its 10-year median of 13.08 and 227.9% above the Medical Distribution industry median of 2.57. SMD Rise PCL's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100), the current Return-on-Tangible-Asset is 8.41% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿1.62 is trading 69.3% below its estimated GF Value™ of ฿5.28.
GuruFocus considers SMD Rise PCL to be Possible Value Trap.
Key valuation signals for BKK:SMD100:
Return-on-Tangible-Asset: 8.41% (36% below median its 10-year median of 13.08)
GF Value™: ฿5.28 vs. price of ฿1.62 (69.3% below fair value)
Industry Position: 227.9% above the Medical Distribution median (#45 of 120)
No single metric tells the full story. See the BKK:SMD100 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
61GF Score
Get the complete analysis for BKK:SMD100
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100 has been successfully added to your 
